Centessa Pharmaceuticals plc - 8-K Filing
Centessa Pharmaceuticals filed to announce that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired on May 21, 2026 for its acquisition by Eli Lilly and Company. The Acquisition remains subject to shareholder approval and High Court sanction of a scheme of arrangement. (Items: 8.01 Other Events)
Tickers: $CNTA